Comerica Bank’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $1.6B | Sell |
1,485,360
-9,402
| -0.6% | -$8.99M | 6.37% | 1 |
|
|
2025
Q3 | $1.14B | Sell |
1,494,762
-7,898
| -0.5% | -$5.88M | 4.29% | 1 |
|
|
2025
Q2 | $1.17B | Buy |
1,502,660
+1,580
| +0.1% | +$1.23M | 4.55% | 1 |
|
|
2025
Q1 | $1.24B | Sell |
1,501,080
-2,583
| -0.2% | -$2.15M | 5.21% | 1 |
|
|
2024
Q4 | $1.16B | Sell |
1,503,663
-7,957
| -0.5% | -$6.59M | 4.68% | 1 |
|
|
2024
Q3 | $1.34B | Sell |
1,511,620
-1,363
| -0.1% | -$1.23M | 5.3% | 1 |
|
|
2024
Q2 | $1.37B | Buy |
1,512,983
+631,312
| +72% | +$505M | 5.7% | 1 |
|
|
2024
Q1 | $686M | Sell |
881,671
-5,453
| -0.6% | -$3.88M | 2.96% | 3 |
|
|
2023
Q4 | $517M | Buy |
887,124
+243,366
| +38% | +$142M | 2.38% | 3 |
|
|
2023
Q3 | $346M | Buy |
+643,758
| New | +$332M | 1.8% | 4 |
|
|
2022
Q4 | $58.2M | Buy |
162,609
+8,328
| +5% | +$2.95M | 0.45% | 32 |
|
|
2022
Q3 | $53.7M | Sell |
154,281
-3,073
| -2% | -$974K | 0.45% | 32 |
|
|
2022
Q2 | $51.3M | Buy |
157,354
+25,209
| +19% | +$7.57M | 0.42% | 35 |
|
|
2022
Q1 | $38.7M | Sell |
132,145
-348
| -0.3% | -$89.6K | 0.28% | 57 |
|
|
2021
Q4 | $31.7M | Buy |
132,493
+1,854
| +1% | +$470K | 0.23% | 70 |
|
|
2021
Q3 | $31.8M | Sell |
130,639
-35,364
| -21% | -$8.73M | 0.19% | 87 |
|
|
2021
Q2 | $44.9M | Sell |
166,003
-2,846
| -2% | -$572K | 0.27% | 57 |
|
|
2021
Q1 | $31.9M | Sell |
168,849
-18,934
| -10% | -$3.7M | 0.19% | 86 |
|
|
2020
Q4 | $38.7M | Sell |
187,783
-8,023
| -4% | -$1.2M | 0.25% | 65 |
|
|
2020
Q3 | $27.9M | Sell |
195,806
-12,939
| -6% | -$2M | 0.2% | 87 |
|
|
2020
Q2 | $34.4M | Buy |
208,745
+18,559
| +10% | +$2.85M | 0.27% | 67 |
|
|
2020
Q1 | $31M | Sell |
190,186
-6,824
| -3% | -$938K | 0.28% | 63 |
|
|
2019
Q4 | $28.1M | Sell |
197,010
-4,261
| -2% | -$494K | 0.21% | 86 |
|
|
2019
Q3 | $21.7M | Sell |
201,271
-2,025
| -1% | -$225K | 0.17% | 99 |
|
|
2019
Q2 | $21.8M | Sell |
203,296
-4,705
| -2% | -$554K | 0.17% | 101 |
|
|
2019
Q1 | $26.5M | Sell |
208,001
-31,183
| -13% | -$3.79M | 0.21% | 85 |
|
|
2018
Q4 | $27.7M | Buy |
239,184
+4,344
| +2% | +$485K | 0.24% | 75 |
|
|
2018
Q3 | $25.9M | Sell |
234,840
-53,882
| -19% | -$5.39M | 0.21% | 86 |
|
|
2018
Q2 | $25.9M | Buy |
288,722
+14,954
| +5% | +$1.23M | 0.18% | 95 |
|
|
2018
Q1 | $21.8M | Sell |
273,768
-28,369
| -9% | -$2.28M | 0.16% | 116 |
|
|
2017
Q4 | $25.5M | Sell |
302,137
-731
| -0.2% | -$62.2K | 0.17% | 108 |
|
|
2017
Q3 | $25M | Sell |
302,868
-99
| -0% | -$8.12K | 0.18% | 97 |
|
|
2017
Q2 | $25.7M | Sell |
302,967
-13
| -0% | -$1.06K | 0.19% | 95 |
|
|
2017
Q1 | $24.6M | Sell |
302,980
-445
| -0.1% | -$35.6K | 0.19% | 98 |
|
|
2016
Q4 | $23.5M | Buy |
303,425
+7,147
| +2% | +$532K | 0.19% | 105 |
|
|
2016
Q3 | $24.1M | Buy |
296,278
+2,555
| +0.9% | +$205K | 0.21% | 90 |
|
|
2016
Q2 | $23.9M | Sell |
293,723
-14,351
| -5% | -$1.08M | 0.21% | 92 |
|
|
2016
Q1 | $23.3M | Buy |
308,074
+5,996
| +2% | +$454K | 0.21% | 90 |
|
|
2015
Q4 | $24.5M | Sell |
302,078
-2,044
| -0.7% | -$170K | 0.24% | 78 |
|
|
2015
Q3 | $25.5M | Sell |
304,122
-353,772
| -54% | -$29.9M | 0.24% | 77 |
|
|
2015
Q2 | $54.9M | Buy |
657,894
+339,454
| +107% | +$25.9M | 0.24% | 93 |
|
|
2015
Q1 | $23.1M | Sell |
318,440
-300,094
| -49% | -$21.4M | 0.2% | 114 |
|
|
2014
Q4 | $42.7M | Buy |
618,534
+338,854
| +121% | +$22.9M | 0.18% | 117 |
|
|
2014
Q3 | $18.1M | Sell |
279,680
-13,601
| -5% | -$861K | 0.16% | 126 |
|
|
2014
Q2 | $18.2M | Sell |
293,281
-89,584
| -23% | -$5.34M | 0.16% | 128 |
|
|
2014
Q1 | $22.5M | Sell |
382,865
-146,610
| -28% | -$8.18M | 0.17% | 121 |
|
|
2013
Q4 | $27M | Sell |
529,475
-88,644
| -14% | -$4.44M | 0.21% | 92 |
|
|
2013
Q3 | $31.1M | Sell |
618,119
-19,710
| -3% | -$1.03M | 0.22% | 84 |
|
|
2013
Q2 | $31.3M | Buy |
+637,829
| New | +$34.7M | 0.26% | 67 |
|
Other funds holding LLY
Comerica Bank's LLY Position: Q4 2025 in Review
Comerica Bank reduced its Eli Lilly (LLY) stake by 0.63% in Q4 2025, selling an estimated $8.99M and leaving 1,485,360 shares worth $1.6B. The position accounts for 6.37% of the portfolio, ranked #1.
Comerica Bank first reported a position in LLY in Q2 2013 and has held it in 49 quarters since. 4,429 funds tracked by Wall St. Rank hold LLY as of Q4 2025.
- Comerica Bank held 1,485,360 shares of Eli Lilly worth $1.6B as of Q4 2025.
- Comerica Bank sold 9,402 Eli Lilly shares in Q4 2025, an estimated $8.99M.
- Eli Lilly made up 6.37% of Comerica Bank's portfolio in Q4 2025, its #1 holding.
- Comerica Bank first reported a position in Eli Lilly in Q2 2013 and has held it in 49 quarters since.
- 4,429 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2025.
Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.